News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
256,265 Results
Type
Article (5951)
Company Profile (28)
Press Release (250286)
Multimedia
Podcasts (3)
Webinars (5)
Section
Business (87732)
Career Advice (472)
Deals (16492)
Drug Delivery (10)
Drug Development (21250)
Employer Resources (32)
FDA (4061)
Job Trends (4567)
News (129926)
Policy (8508)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (348)
Accelerated approval (12)
Adcomms (4)
Allergies (21)
Alliances (16232)
ALS (57)
Alzheimer's disease (414)
Antibody-drug conjugate (ADC) (82)
Approvals (4229)
Artificial intelligence (151)
Autoimmune disease (71)
Automation (10)
Bankruptcy (107)
Best Places to Work (3389)
Biosimilars (41)
Biotechnology (29)
Bladder cancer (49)
Brain cancer (18)
Breast cancer (176)
Cancer (1293)
Cardiovascular disease (89)
Career advice (405)
Career pathing (4)
CAR-T (79)
CDC (4)
Celiac Disease (1)
Cell therapy (207)
Cervical cancer (8)
Clinical research (18872)
Collaboration (511)
Compensation (465)
Complete response letters (13)
COVID-19 (466)
CRISPR (17)
C-suite (495)
Cystic fibrosis (30)
Data (1952)
Denatured (2)
Depression (32)
Dermatology (22)
Diabetes (109)
Diagnostics (2414)
Digital health (12)
Diversity (1)
Diversity, equity & inclusion (14)
Drug discovery (66)
Drug pricing (15)
Drug shortages (2)
Duchenne muscular dystrophy (53)
Earnings (45960)
Editorial (5)
Employer branding (6)
Employer resources (34)
Events (42676)
Executive appointments (502)
FDA (5002)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (7)
Frontotemporal dementia (14)
Funding (460)
Gene editing (31)
Generative AI (7)
Gene therapy (120)
GLP-1 (177)
Government (550)
Guidances (209)
Healthcare (5624)
HIV (14)
Huntington's disease (6)
IgA nephropathy (23)
Immunology and inflammation (48)
Immuno-oncology (16)
Indications (36)
Infectious disease (510)
Inflammatory bowel disease (38)
Inflation Reduction Act (3)
Influenza (10)
Intellectual property (41)
Interviews (57)
IPO (8482)
IRA (3)
Job creations (1262)
Job search strategy (366)
JPM (4)
Kidney cancer (13)
Labor market (13)
Layoffs (117)
Leadership (6)
Legal (2723)
Liver cancer (22)
Longevity (5)
Lung cancer (140)
Lymphoma (90)
Machine learning (10)
Management (11)
Manufacturing (216)
MASH (59)
Medical device (4403)
Medtech (4435)
Mergers & acquisitions (8536)
Metabolic disorders (287)
mRNA (16)
Multiple sclerosis (26)
NASH (6)
Neurodegenerative disease (85)
Neuropsychiatric disorders (15)
Neuroscience (763)
NextGen: Class of 2026 (1793)
Non-profit (799)
Now hiring (7)
Obesity (113)
Opinion (34)
Ovarian cancer (43)
Pain (43)
Pancreatic cancer (75)
Parkinson's disease (73)
Partnered (12)
Patents (79)
Patient recruitment (142)
Peanut (6)
People (27471)
Pharmaceutical (11)
Pharmacy benefit managers (2)
Phase 1 (5606)
Phase 2 (8321)
Phase 3 (6521)
Pipeline (3340)
Policy (24)
Postmarket research (660)
Preclinical (2208)
Press Release (67)
Prostate cancer (82)
Psychedelics (5)
Radiopharmaceuticals (143)
Rare diseases (239)
Real estate (2031)
Recruiting (9)
Regulatory (6331)
Reports (19)
Research institute (361)
Resumes & cover letters (69)
Rett syndrome (25)
RNA editing (5)
RSV (2)
Schizophrenia (66)
Series A (70)
Series B (68)
Service/supplier (2)
Sickle cell disease (16)
Special edition (1)
Spinal muscular atrophy (38)
Sponsored (7)
Startups (1133)
State (1)
Stomach cancer (1)
Supply chain (21)
Tariffs (7)
The Weekly (1)
Vaccines (127)
Venture capital (14)
Weight loss (40)
Women's health (11)
Worklife (1)
Date
Today (25)
Last 7 days (146)
Last 30 days (1198)
Last 365 days (9929)
2026 (4388)
2025 (10080)
2024 (12208)
2023 (14506)
2022 (20473)
2021 (21858)
2020 (19714)
2019 (14306)
2018 (11009)
2017 (10870)
2016 (10000)
2015 (13154)
2014 (10372)
2013 (8354)
2012 (9045)
2011 (9449)
2010 (9259)
Location
Africa (201)
Alabama (20)
Alaska (2)
Arizona (92)
Arkansas (2)
Asia (12659)
Australia (1795)
California (4407)
Canada (2058)
China (220)
Colorado (180)
Connecticut (210)
Delaware (91)
Europe (27436)
Florida (688)
Georgia (99)
Idaho (24)
Illinois (208)
India (30)
Indiana (178)
Iowa (9)
Japan (234)
Kansas (41)
Kentucky (21)
Louisiana (11)
Maine (57)
Maryland (427)
Massachusetts (3544)
Michigan (153)
Minnesota (260)
Mississippi (1)
Missouri (40)
Montana (18)
Nebraska (14)
Nevada (61)
New Hampshire (27)
New Jersey (1462)
New Mexico (8)
New York (1101)
North Carolina (614)
North Dakota (5)
Northern California (2342)
Ohio (141)
Oklahoma (9)
Oregon (7)
Pennsylvania (843)
Puerto Rico (4)
Rhode Island (20)
South America (312)
South Carolina (20)
Southern California (1650)
Tennessee (84)
Texas (708)
United States (16014)
Utah (142)
Virginia (103)
Washington D.C. (17)
Washington State (379)
West Virginia (2)
Wisconsin (86)
Wyoming (2)
256,265 Results for "apotex corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Apotex announces leadership changes
March 30, 2026
·
2 min read
Press Releases
Apotex launches Apo‑Semaglutide Injection™, a generic equivalent of Ozempic®, in Canada
May 14, 2026
·
2 min read
Press Releases
Apotex Announces Strategic U.S. Sterile Filling Partnership with Halo Pharmaceuticals
April 15, 2026
·
3 min read
Press Releases
Apotex Receives First U.S. FDA Tentative Approval for a Generic Version of Ozempic® (Semaglutide Injection) in Partnership with Orbicular
April 12, 2026
·
2 min read
Press Releases
Apotex Announces Strategic Transaction with Cumberland Pharmaceuticals to Integrate their U.S. Branded Businesses
April 23, 2026
·
3 min read
Press Releases
Apotex becomes the first Canadian‑based pharmaceutical company to receive Health Canada approval for a generic equivalent of Ozempic®
May 4, 2026
·
3 min read
Press Releases
Apotex Strengthens Osteoporosis Care in Canada with Health Canada’s Approval of DENOZA™, a Denosumab Biosimilar
April 7, 2026
·
2 min read
Press Releases
Apotex Announces FDA Approval of Generic Infuvite® Pediatric Injection, Eligible for 180‑day CGT Exclusivity (Single‑Dose Vial), Complementing its Recent Approval of Generic Infuvite Adult Injection
April 27, 2026
·
2 min read
Press Releases
Apotex Announces FDA Approval of First Generic Infuvite® Adult Injection (Single Dose Vial and Pharmacy Bulk package) with 180‑Day CGT Exclusivity for the Pharmacy bulk package in Partnership with Orbicular and Gland Pharma
April 14, 2026
·
4 min read
Press Releases
Apotex Expands Canadian Ophthalmology Portfolio with Health Canada’s Approval of CLOBIVIS™ (Clobetasol Propionate Ophthalmic Suspension, 0.05%)
March 25, 2026
·
1 min read
1 of 25,627
Next
